SMi’s 3rd Annual Biobanking conference will aim to bring together key solution providers and potential clients affiliated with pharmaceutical companies and Biobanking institutions alike.

Benefits of Attending:

• Unique insights into building and developing a successful biobanking infrastructure
• Explore novel technologies for managing biobanks - Radio Frequency Identification (RFID)
• Promote availability and maximise value from biospecimen collections
• Investigate ways in which biobanks can contribute to stratified medicines
• Interactive platform for networking between academia and industry
• Spotlight on ground-breaking topics that expose commercial opportunities for future investments
• Highlight global regulatory, legal and ethical compliance considerations

The first 2 instalments in the Biobanking series received great feedback from the industry. Comments included Roche – “‘‘Entertaining and informative’’, Merck - ‘‘Stimulated, good discussions and provided good feedback on questions’’ and GSK - ‘‘Detailed and specific’’

For further information click here